Stock Analiz

Carlsmed, Inc. (CARL) stock forecast and price target

Price $17.12 · data as of November 13, 2026

12-month price target

Average target$22.00
Upside / downside+28.5%
Analysts5
ConsensusStrong buy
Low $18.00Average $22.00High $26.00

Gold marker: average target · white marker: today’s price ($17.12)

Analyst ratings

Strong buy 2Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.51+23.2%$79M
Next fiscal year
ends December 31, 2027
$-1.56−3.3%$112M
Quarter after
ends December 31, 2026
$-0.35−18.9%$24M

Consensus of the analysts covering Carlsmed, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 28.5% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Carlsmed’s intrinsic value about 87% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Carlsmed stock price target?

The average 12-month target from 5 analysts is $22.00, 28.5% above the current price of $17.12 Targets range from $18.00 to $26.00.

Is Carlsmed a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Carlsmed expected to earn?

Analysts expect EPS of $-1.51 for the fiscal year ending December 31, 2026 and $-1.56 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.